Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
"Thiazide is the standard treatment for calcium stones, so this [new research] has the potential to upset the basket," one observer said.
Read Full NewsThe rheumatology month in review emphasizes new data presented at the 2025 ACR Convergence.
A compilation of 13 trials presented as late-breaking data at ACR Convergence 2025.
New research at ACR 2025 highlights the link between cognitive impairment and disease activity in SLE.
Explore groundbreaking advancements in healthcare as 2025 concludes, featuring expert insights and dynamic multimedia.
This rheumatology month in review emphasizes new data from the ACR Convergence.
New data support firsekibart's efficacy over colchicine for preventing acute gout flares.
A new study reveals ligdolinurad effectively lowers uric acid levels in gout patients, showcasing promising safety and tolerability results.
1.
New protein target discovered for childhood medulloblastomas
2.
The New Canadian Guidelines for Drinking at High Risk, AUD.
3.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
4.
Study finds 81% of cancer cures touted by TikTok videos are fake
5.
Taking the "Boob Bus"; Reluctance to Grant Prior Authorization; Alcohol's Carcinogenic Potential?
1.
The Mysterious World of Petechiae: Exploring Causes and Treatments
2.
How Bispecific Antibodies are Redefining Medical Oncology in the US - A 2025 Review
3.
Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy
4.
Unlocking the Secrets of Hemoglobin: How It Works to Keep Us Healthy
5.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
Navigating the Complexities of Ph Negative ALL - Part IX
3.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
4.
Should We Use DARA Up Front As First-Line Therapy in MM?
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge